BioRestorative Therapies (BRTX) Expected to Announce Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTX) is anticipated to release its earnings data on Thursday, March 27th. Analysts expect BioRestorative Therapies to post earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Performance

Shares of BRTX stock opened at $1.92 on Wednesday. The firm has a fifty day moving average of $1.98 and a 200-day moving average of $1.72. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The stock has a market cap of $13.29 million, a price-to-earnings ratio of -1.25 and a beta of 64.37.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.